Table 2 Device characteristics
Devices | ( n = 21) |
|---|---|
Indication for implantation | |
Ischemic cardiomyopathy, n (%) | 7 (33.3) |
Non-ischemic cardiomyopathy, n (%) | 14 (66.7) |
Long QT syndrome, n (%) | 1 (4.8) |
ARVC, n (%) | 2 (9.5) |
Secondary prophylaxis, n (%) | 11 (52.4) |
Explanted | |
VVI-ICD, n (%) | 5 (23.8) |
DDD-ICD, n (%) | 6 (28.6) |
CRT-D, n (%) | 10 (47.6) |
Reimplanted | |
VVI-ICD, n (%) | 6 (28.6) |
DDD-ICD, n (%) | 3 (14.3) |
CRT-D, n (%) | 9 (42.8) |
S-ICD, n (%) | 3 (14.3) |
Time to re-implantation, days | 51.6 ± 16.9 |